• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单环刺鼠相关蛋白(103 - 122)精氨酸 - 苯丙氨酸 - 苯丙氨酸残基的立体化学研究:将一种黑皮质素 - 4受体拮抗剂转化为激动剂,并发现一种强效且选择性的黑皮质素 - 1激动剂。

Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.

作者信息

Joseph Christine G, Wang Xiang S, Scott Joseph W, Bauzo Rayna M, Xiang Zhimin, Richards Nigel G, Haskell-Luevano Carrie

机构信息

Department of Medicinal Chemistry, University of Florida, Gainesville, FL 32610, USA.

出版信息

J Med Chem. 2004 Dec 30;47(27):6702-10. doi: 10.1021/jm0492756.

DOI:10.1021/jm0492756
PMID:15615519
Abstract

The agouti-related protein (AGRP) is an endogenous antagonist of the centrally expressed melanocortin receptors. The melanocortin-4 receptor (MC4R) is involved in energy homeostasis, food intake, sexual function, and obesity. The endogenous hAGRP protein is 132 amino acids in length, possesses five disulfide bridges at the C-terminus of the molecule, and is expressed in the hypothalamus of the brain. We have previously reported that a monocyclic hAGRP(103-122) peptide is an antagonist at the melanocortin receptors expressed in the brain. Stereochemical inversion from the endogenous l- to d-isomers of single or multiple amino acid modifications in this monocyclic truncated hAGRP sequence resulted in molecules that are converted from melanocortin receptor antagonists into melanocortin receptor agonists. The Asp-Pro-Ala-Ala-Thr-Ala-Tyr-cyclo[Cys-Arg-DPhe-DPhe-Asn-Ala-Phe-Cys]-Tyr-Ala-Arg-Lys-Leu peptide resulted in a 60 nM melanocortin-1 receptor agonist that is 100-fold selective versus the mMC4R, 1000-fold selective versus the mMC3R, and ca. 180-fold selective versus the mMC5R. In attempts to identify putative ligand-receptor interactions that may be participating in the agonist induced stimulation of the MC4R, selected ligands were docked into a homology molecular model of the mMC4R. These modeling studies have putatively identified hAGRP ligand DArg111-mMC4RAsn115 (TM3) and the hAGRP DPhe113-mMC4RPhe176 (TM4) interactions as important for agonist activity.

摘要

刺鼠相关蛋白(AGRP)是中枢表达的黑皮质素受体的内源性拮抗剂。黑皮质素-4受体(MC4R)参与能量平衡、食物摄入、性功能和肥胖。内源性hAGRP蛋白长度为132个氨基酸,在分子的C末端具有五个二硫键,并在大脑的下丘脑表达。我们之前报道过,单环hAGRP(103 - 122)肽是大脑中表达的黑皮质素受体的拮抗剂。在这个单环截短的hAGRP序列中,单个或多个氨基酸修饰从内源性L-异构体立体化学转化为D-异构体,导致分子从黑皮质素受体拮抗剂转变为黑皮质素受体激动剂。天冬氨酸-脯氨酸-丙氨酸-丙氨酸-苏氨酸-丙氨酸-酪氨酸-环[半胱氨酸-精氨酸-D-苯丙氨酸-D-苯丙氨酸-天冬酰胺-丙氨酸-苯丙氨酸-半胱氨酸]-酪氨酸-丙氨酸-精氨酸-赖氨酸-亮氨酸肽产生了一种60 nM的黑皮质素-1受体激动剂,对mMC4R的选择性为100倍,对mMC3R的选择性为1000倍,对mMC5R的选择性约为180倍。为了确定可能参与激动剂诱导的MC4R刺激的假定配体-受体相互作用,将选定的配体对接至mMC4R的同源分子模型中。这些建模研究推测确定hAGRP配体DArg111-mMC4RAsn115(跨膜区3)和hAGRP DPhe113-mMC4RPhe176(跨膜区4)相互作用对激动剂活性很重要。

相似文献

1
Stereochemical studies of the monocyclic agouti-related protein (103-122) Arg-Phe-Phe residues: conversion of a melanocortin-4 receptor antagonist into an agonist and results in the discovery of a potent and selective melanocortin-1 agonist.单环刺鼠相关蛋白(103 - 122)精氨酸 - 苯丙氨酸 - 苯丙氨酸残基的立体化学研究:将一种黑皮质素 - 4受体拮抗剂转化为激动剂,并发现一种强效且选择性的黑皮质素 - 1激动剂。
J Med Chem. 2004 Dec 30;47(27):6702-10. doi: 10.1021/jm0492756.
2
Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.通过同源分子建模和使用嵌合肽配体进行验证来鉴定假定的刺鼠相关蛋白(87-132)-促黑素皮质素4受体相互作用。
J Med Chem. 2004 Apr 22;47(9):2194-207. doi: 10.1021/jm0303608.
3
Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.独特且强效的刺鼠相关蛋白(AGRP)-促黑素细胞皮质素嵌合肽Tyr-c[β-天冬氨酸-组氨酸-二苯丙氨酸-精氨酸-色氨酸-天冬酰胺-丙氨酸-苯丙氨酸-二肽基脯氨酸]-Tyr-NH2的构效关系。
J Med Chem. 2005 Apr 21;48(8):3060-75. doi: 10.1021/jm049010r.
4
Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.一种强效的(半胱氨酸101-半胱氨酸119,半胱氨酸110-半胱氨酸117)双环刺鼠相关蛋白(AGRP)黑皮质素受体拮抗剂的结构表征与药理学研究
J Med Chem. 2004 Nov 4;47(23):5662-73. doi: 10.1021/jm049620r.
5
Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants.通过体外诱变对黑皮质素-4受体进行的结构活性研究:刺鼠相关蛋白(AGRP)、黑皮质素激动剂和合成肽拮抗剂相互作用决定因素的鉴定。
Biochemistry. 2001 May 22;40(20):6164-79. doi: 10.1021/bi010025q.
6
Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.带有刺鼠相关蛋白(AGRP)的精氨酸-苯丙氨酸-苯丙氨酸氨基酸的嵌合NDP-MSH和MTII促黑素细胞激素肽具有促黑素细胞激素受体激动剂活性。
Peptides. 2003 Dec;24(12):1899-908. doi: 10.1016/j.peptides.2003.10.005.
7
Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphisms.肽和小分子可挽救功能失调的人类黑皮质素-4受体多态性的功能活性和激动剂效力。
Biochemistry. 2007 Jul 17;46(28):8273-87. doi: 10.1021/bi7007382. Epub 2007 Jun 23.
8
Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.40种人类黑皮质素-4受体多态性与内源性阿片促黑皮质素衍生激动剂及刺鼠相关蛋白(AGRP)拮抗剂的药理学特征
Biochemistry. 2006 Jun 13;45(23):7277-88. doi: 10.1021/bi0600300.
9
Receptor-antagonist interactions in the complexes of agouti and agouti-related protein with human melanocortin 1 and 4 receptors.刺鼠信号蛋白和刺鼠相关蛋白与人促黑素细胞激素1型和4型受体复合物中的受体 - 拮抗剂相互作用
Biochemistry. 2005 Mar 8;44(9):3418-31. doi: 10.1021/bi0478704.
10
Novel agouti-related-protein-based melanocortin-1 receptor antagonist.新型基于刺鼠相关蛋白的促黑素皮质素-1受体拮抗剂。
J Med Chem. 2001 Nov 22;44(24):4114-24. doi: 10.1021/jm010215z.

引用本文的文献

1
Macrocyclic Modalities Combining Peptide Epitopes and Natural Product Fragments.结合肽表位和天然产物片段的大环化合物
J Am Chem Soc. 2020 Mar 11;142(10):4904-4915. doi: 10.1021/jacs.0c00269. Epub 2020 Mar 2.
2
Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.在 AgRP 衍生的大环支架 c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] 中加入 Agouti 相关蛋白 (AgRP) 的人类单核苷酸多态性 (SNPs) 会降低黑皮质素 4 受体拮抗剂的效力,并导致发现黑皮质素 5 受体拮抗剂。
J Med Chem. 2020 Mar 12;63(5):2194-2208. doi: 10.1021/acs.jmedchem.9b00860. Epub 2020 Jan 6.
3
Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.在环状 Agouti 相关蛋白拮抗剂支架 c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro]中进行 Arg-Phe-Phe d-氨基酸立体化学扫描导致意想不到的黑素皮质素-1 受体激动剂特性。
ACS Chem Neurosci. 2018 Dec 19;9(12):3015-3023. doi: 10.1021/acschemneuro.8b00218. Epub 2018 Jul 20.
4
Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa-Arg-(pI)DPhe-Xaa-NH.基于序列Ac-Xaa-Arg-(pI)DPhe-Xaa-NH发现混合药理学的促黑素皮质素-3激动剂和促黑素皮质素-4受体四肽拮抗剂化合物(TACOs)
J Med Chem. 2017 May 25;60(10):4342-4357. doi: 10.1021/acs.jmedchem.7b00301. Epub 2017 May 15.
5
Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.发现一种β-发夹八肽c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro],其模拟刺鼠相关蛋白(87 - 132)[AGRP(87 - 132)],具有等效的小鼠促黑素皮质素-4受体(mMC4R)拮抗剂药理学特性。
J Med Chem. 2015 Jun 11;58(11):4638-47. doi: 10.1021/acs.jmedchem.5b00184. Epub 2015 Apr 21.
6
Flexible modulation of agonist efficacy at the human A3 adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000.咪唑喹啉变构增强剂LUF6000对人A3腺苷受体激动剂效力的灵活调节
BMC Pharmacol. 2008 Dec 12;8:20. doi: 10.1186/1471-2210-8-20.